These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8287352)

  • 1. CMA issues revised guidelines on physicians' relationship with pharmaceutical industry.
    Williams JR
    CMAJ; 1994 Jan; 150(2):263, 265. PubMed ID: 8287352
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicians and the pharmaceutical industry (update 1994). Canadian Medical Association.
    CMAJ; 1994 Jan; 150(2):256A-256F. PubMed ID: 8287348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMA guidelines concerning relationship of MDs and drug industry to be revised, board told.
    Sullivan P
    CMAJ; 1993 Jan; 148(2):273-5. PubMed ID: 11652162
    [No Abstract]   [Full Text] [Related]  

  • 4. CMA guidelines on MD-drug industry relations part of international trend.
    Williams JR
    CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902
    [No Abstract]   [Full Text] [Related]  

  • 5. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more.
    Rapp MS; Woollard R
    CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303
    [No Abstract]   [Full Text] [Related]  

  • 6. General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
    Williams JR
    CMAJ; 1993 Aug; 149(3):335-7. PubMed ID: 11659649
    [No Abstract]   [Full Text] [Related]  

  • 7. The CMA's MD-drug industry guidelines offer advice, nothing more.
    Woollard R
    CMAJ; 1991 Dec; 145(11):1498-9. PubMed ID: 11649304
    [No Abstract]   [Full Text] [Related]  

  • 8. The regulatory morass: physicians' dealings with pharmaceutical manufacturers.
    Blehart B
    J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicians and the pharmaceutical industry.
    Dingle B
    CMAJ; 1993 Feb; 148(4):485-6. PubMed ID: 8431808
    [No Abstract]   [Full Text] [Related]  

  • 10. Physicians and the pharmaceutical industry.
    Arkinstall WW
    CMAJ; 1993 Feb; 148(4):485. PubMed ID: 8431807
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
    Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
    Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
    [No Abstract]   [Full Text] [Related]  

  • 12. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines on gifts to physicians from industry: an update.
    American Medical Association. Council on Ethical and Judicial Affairs
    Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909
    [No Abstract]   [Full Text] [Related]  

  • 14. Physicians and the pharmaceutical industry.
    Canadian Medical Association
    CMAJ; 1992 Feb; 146(3):388A-C. PubMed ID: 11654903
    [No Abstract]   [Full Text] [Related]  

  • 15. Revised Code of Ethics wins CMA approval.
    Rafuse J
    CMAJ; 1996 Oct; 155(8):1148-9. PubMed ID: 8873640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of ethics in gastroenterology: joint meeting of the members of JSGE and OMGE.
    International Workshop on Promotion of Ethics in Gastroenterology, Tokyo, Japan, 8-10 Apr 1992
    Gastroenterol Jpn; 1993 Jul; 28(Suppl. 6):45-54. PubMed ID: 11654959
    [No Abstract]   [Full Text] [Related]  

  • 17. The Medical Council of India guidelines on industry-physician relationship: breaking the conspiracy of silence.
    Nagral J; Roy N
    Natl Med J India; 2010; 23(2):69-71. PubMed ID: 20925200
    [No Abstract]   [Full Text] [Related]  

  • 18. Academic medicine and the pharmaceutical industry: a cautionary tale.
    Guyatt G
    CMAJ; 1994 Mar; 150(6):951-3. PubMed ID: 8131127
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
    Sergeant MD; Hodgetts PG; Godwin M; Walker DM; McHenry P
    CMAJ; 1996 Nov; 155(9):1243-8. PubMed ID: 8911290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.